TITLE

Novelo To Raise $15M For Lung Cancer, Hep C

PUB. DATE
April 2007
SOURCE
Bioworld Week;4/23/2007, Vol. 15 Issue 17, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the financing deal of Novelos Therapeutics Inc. to raise $15 million for its phase III study with NV-002 for lung cancer treatment in Newton, Massachusetts. The company stated that as part of the deal is the sale of its 1,500 shares of Series B convertible preferred stock with a stated value of $10,000 per share. The company said that the firm would get about $10 million more for the pipeline if all the warrants involved in the financing deal are exercised for cash.
ACCESSION #
25089965

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics